Potential γ-hydroxybutyric acid (GHB) drug interactions through blood-brain barrier transport inhibition : A pharmacokinetic simulation-based evaluationBHATTACHARYA, Indranil; BOJE, Kathleen M. K.Journal of pharmacokinetics and pharmacodynamics (Print). 2006, Vol 33, Num 5, pp 657-681, issn 1567-567X, 25 p.Article

A critical evaluation of the Brain Efflux Index method as applied to the nitric oxide synthase inhibitor, aminoguanidineRAYBON, Joseph J; BOJE, Kathleen M. K.Biopharmaceutics & drug disposition. 2001, Vol 22, Num 9, pp 391-401, issn 0142-2782Article

Feasibility of D-glucuronate to enhance γ-hydroxybutyric acid metabolism during γ-hydroxybutyric acid toxicity : Pharmacokinetic and pharmacodynamic studiesBHATTACHARYA, Indranil; BOJE, Kathleen M. K.Biopharmaceutics & drug disposition. 2007, Vol 28, Num 1, pp 1-11, issn 0142-2782, 11 p.Article

Theoretical pharmacokinetic and pharmacodynamic simulations of drug delivery mediated by blood-brain barrier transportersDOAN, Kelly M; BOJE, Kathleen M. K.Biopharmaceutics & drug disposition. 2000, Vol 21, Num 7, pp 261-278, issn 0142-2782Article

Alterations in neuronal transport but not blood-brain barrier transport are observed during gamma-hydroxybutyrate (GHB) sedative/hypnotic toleranceBHATTACHARYA, Indranil; RAYBON, Joseph J; BOJE, Kathleen M. K et al.Pharmaceutical research. 2006, Vol 23, Num 9, pp 2067-2077, issn 0724-8741, 11 p.Article

Blood-brain barrier transport studies of organic guanidino cations using an in situ brain perfusion techniqueMAHAR DOAN, Kelly M; LAKHMAN, Sukhwinder S; BOJE, Kathleen M. K et al.Brain research. 2000, Vol 876, Num 1-2, pp 141-147, issn 0006-8993Article